Kids' blood clot treatment under review: how safe are common thinners?
NCT ID NCT06278051
First seen May 12, 2026 · Last updated May 14, 2026 · Updated 1 time
Summary
This study looks at medical records of children under 18 in Japan who were prescribed rivaroxaban or warfarin for blood clots. Researchers want to see how often serious bleeding happens with each drug in everyday care. No extra tests or visits are needed—only existing health data is used.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bayer
Osaka, 530-0001, Japan
-
Many facilities
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.